José Navarro‐Partida

Author

Also Known As

J Navarro-Partida, J. Navarro-Partida, Jose Navarro-Partida, Jose Navarro-Partıda, Jose Navarro‐Partida, José Navarro-Partida, José Navarro‐Partida, Navarro-Partida José, Navarro-Partida, Jose

Publications

Citations

H-Index

Concepts

All Affiliations

Universidad de Guadalajara Tecnológico de Monterrey Centro de Retina Médica y Quirúrgica Hospital Civil de Guadalajara Institute for Social Security and Services for State Workers

About

José Navarro‐Partida is an author at Universidad de Guadalajara specializing in medicine, glaucoma, and ophthalmology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	80
2	Cell Biology	1	1	32
3	Diabetes	1	1	25
4	Hepatology	1	1	32
5	Pathology	1	1	32

José Navarro‐Partida

Publications

573

Citations

H-Index

Page 1

	Year	Citations
The multifaceted role of pirfenidone and its novel targets José Macías‐Barragán, Ana Sandoval-Rodríguez, José Navarro‐Partida, Fibrogenesis & Tissue Repair	2010	158
Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery Juan Carlos Altamirano-Vallejo, José Navarro‐Partida, Alejandro González‐De la Rosa, Journal of Ocular Pharmacology and Therapeutics	2018	63
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK Ana Sandoval-Rodríguez, Hugo Christian Monroy-Ramírez, Alejandra Meza-Ríos, Hepatology Communications	2020	49
Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study Alejandro González‐De la Rosa, José Navarro‐Partida, Juan Carlos Altamirano-Vallejo, Journal of Ocular Pharmacology and Therapeutics	2019	34
Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis José Navarro‐Partida, Abril Bernardette Martínez-Rizo, J. González-Cuevas, European Journal of Pharmacology Th2 DifferentiationFibrosisLimits Th2 ResponseHepatologyMedicine	2011	32
Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial Luz Elena Gasca-Lozano, Silvia Lucano‐Landeros, Héctor Ruiz-Mercado, Journal of Diabetes Research	2017	31
Adenoviral delivery of dominant‐negative transforming growth factor β type II receptor up‐regulates transcriptional repressor SKI‐like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats Ana Laura Márquez-Aguirre, Ana Sandoval-Rodríguez, J. González-Cuevas, The Journal of Gene Medicine	2009	25
Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema José Navarro‐Partida, Juan Carlos Altamirano-Vallejo, Alejandro González‐De la Rosa, Pharmaceutics Biologic ActivityDiabetic RetinopathyRetinal DiseasesOcular DiseaseVitreous Body	2021	25
Association of Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile with the risk of primary open angle glaucoma José Navarro‐Partida, Abril Bernardette Martínez-Rizo, Pedro Ramirez-Barrera, Graefe s Archive for Clinical and Experimental Ophthalmology OphthalmologySingle-nucleotide Polymorphisms Asp299glyGeneticsGenetic EpidemiologyHuman Polymorphism	2017	23
Association of single-nucleotide polymorphisms in non-coding regions of the <i>TLR4</i> gene with primary open angle glaucoma in a Mexican population José Navarro‐Partida, Beatriz Alvarado Castillo, Abril Bernardette Martínez-Rizo, Ophthalmic Genetics	2016	22

Page 1